|
| 1 |
Glycemic Variability: How Do We Measure It and Why Is It Important?
Suh, Sunghwan;Kim, Jae Hyeon;
/
Korean Diabetes Association
, v.39, no.4, pp.273-282,
|
|
| 2 |
Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
Rhee, Sang Youl;Kim, Young Seol;
/
Korean Diabetes Association
, v.39, no.4, pp.283-290,
|
|
| 3 |
Probiotics as Complementary Treatment for Metabolic Disorders
Le Barz, Melanie;Anhe, Fernando F.;Varin, Thibaut V.;Desjardins, Yves;Levy, Emile;Roy, Denis;Urdaci, Maria C.;Marette, Andre;
/
Korean Diabetes Association
, v.39, no.4, pp.291-303,
|
|
| 4 |
Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
Kim, Ji Hyun;
/
Korean Diabetes Association
, v.39, no.4, pp.304-306,
|
|
| 5 |
Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
Jung, Jin-Hee;Lee, Jung-Hwa;Noh, Jin-Won;Park, Jeong-Eun;Kim, Hee-Sook;Yoo, Joo-Wha;Song, Bok-Rye;Lee, Jeong-rim;Hong, Myeong-Hee;Jang, Hyang-Mi;Na, Young;Lee, Hyun-Joo;Lee, Jeong-Mi;Kang, Yang-Gyo;Kim, Sun-Young;Sim, Kang-Hee;
/
Korean Diabetes Association
, v.39, no.4, pp.307-315,
|
|
| 6 |
Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes
Kim, Hee-Sook;Jang, Hye-Jung;Park, Jeong-Eun;Kim, Moon-Young;Ko, Sun-Young;Kim, Sung-Hoon;
/
Korean Diabetes Association
, v.39, no.4, pp.316-320,
|
|
| 7 |
Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population
Bansal, Dipika;Nayakallu, Ramya S.R.;Gudala, Kapil;Vyamasuni, Rajavikram;Bhansali, Anil;
/
Korean Diabetes Association
, v.39, no.4, pp.321-327,
|
|
| 8 |
Maximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes Mellitus
Suk, Min Hwa;Moon, Yeo-Jin;Park, Sung Woo;Park, Cheol-Young;Shin, Yun A;
/
Korean Diabetes Association
, v.39, no.4, pp.328-334,
|
|
| 9 |
Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
Yang, Hae Kyung;Kang, Borami;Lee, Seung-Hwan;Kim, Hun-Sung;Yoon, Kun-Ho;Cha, Bong-Yun;Cho, Jae-Hyoung;
/
Korean Diabetes Association
, v.39, no.4, pp.335-341,
|
|
| 10 |
Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
Yagi, Shusuke;Aihara, Ken-ichi;Akaike, Masashi;Fukuda, Daiju;Salim, Hotimah Masdan;Ishida, Masayoshi;Matsuura, Tomomi;Ise, Takayuki;Yamaguchi, Koji;Iwase, Takashi;Yamada, Hirotsugu;Soeki, Takeshi;Wakatsuki, Tetsuzo;Shimabukuro, Michio;Matsumoto, Toshio;Sata, Masataka;
/
Korean Diabetes Association
, v.39, no.4, pp.342-347,
|
|
| 11 |
Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
Lee, Dae Ho;
/
Korean Diabetes Association
, v.39, no.4, pp.348-349,
|
|
| 12 |
Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
Suh, Sunghwan;Seo, Gi Hyeon;Jung, Chang Hee;Kim, Mee-Kyoung;Jin, Sang-Man;Hwang, You-Cheol;Lee, Byung-Wan;Kim, Jae Hyeon;
/
Korean Diabetes Association
, v.39, no.4, pp.350-351,
|
|